Seagen Inc.
METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES
Last updated:
Abstract:
The invention provides methods of treating cancer, such as myeloid malignancies including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), with nonfucosylated anti-CD70 antibodies.
Status:
Application
Type:
Utility
Filling date:
28 Dec 2020
Issue date:
22 Jul 2021